CompanyTrack
G

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

Active Stevenage

Activities of other holding companies n.e.c.

0 employees
Activities of other holding companies n.e.c.
G

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

Activities of other holding companies n.e.c.

Founded 6 Nov 2012 Active Stevenage, United Kingdom 0 employees
Activities of other holding companies n.e.c.
Accounts Submitted 15 Aug 2025
Confirmation Statement Submitted 22 Sept 2025
Net assets £-17750.94M £1293.62M 2023 year on year
Total assets £2410.35M £235.18M 2023 year on year
Total Liabilities £20161.30M £1528.79M 2023 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY United Kingdom

Credit Report

Discover GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

N/A

Net Assets

-£17750.94M

Decreased by £1293.62M (-8%)

Total Liabilities

£20161.30M

Increased by £1528.79M (+8%)

Turnover

£2397.36M

Increased by £768.84M (+47%)

Employees

N/A

Debt Ratio

836%

Decreased by 21 (-2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

8 active 11 resigned
Status
Adam WalkerDirectorBritishUnited Kingdom5828 Mar 2013Active
Anna Mary Harcourt FentDirectorBritishUnited Kingdom4710 Jul 2025Active
Cristina Barcelo IglesiasDirectorBritishUnited Kingdom4823 Sept 2024Active
Demet Gurunlu RussDirectorTurkishUnited Kingdom5425 Jun 2024Active
Edinburgh Pharmaceutical Industries LimitedCorporate-directorUnited KingdomUnknown6 Nov 2012Active
Edinburgh Pharmaceutical Industries LimitedCorporate-secretaryUnited KingdomUnknown6 Nov 2012Active
Glaxo Group LimitedCorporate-directorUnited KingdomUnknown6 Nov 2012Active
Graham Paul RiversDirectorBritishUnited Kingdom5418 Jul 2023Active

Shareholders

Shareholders (1)

Glaxosmithkline Intellectual Property Management Limited
100.0%
1001 Dec 2015

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxosmithkline Intellectual Property Management Limited

Unknown

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
GSK PLC united kingdom
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
22 Sept 2025Confirmation StatementConfirmation statement made on 2025-09-22 with no updatesView(3 pages)
15 Aug 2025AccountsAnnual accounts made up to 2024-12-31View(31 pages)
31 Jul 2025OfficersChange Corporate Secretary Company With Change DateView(1 page)
31 Jul 2025OfficersChange Corporate Director Company With Change DateView(1 page)
15 Jul 2025OfficersAppointment of Mrs Anna Mary Harcourt Fent as director on 2025-07-10View(2 pages)
22 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-09-22 with no updates

15 Aug 2025 Accounts

Annual accounts made up to 2024-12-31

31 Jul 2025 Officers

Change Corporate Secretary Company With Change Date

31 Jul 2025 Officers

Change Corporate Director Company With Change Date

15 Jul 2025 Officers

Appointment of Mrs Anna Mary Harcourt Fent as director on 2025-07-10

Recent Activity

Latest Activity

Confirmation statement made on 2025-09-22 with no updates

4 months ago on 22 Sept 2025

Annual accounts made up to 2024-12-31

6 months ago on 15 Aug 2025

Change Corporate Secretary Company With Change Date

6 months ago on 31 Jul 2025

Change Corporate Director Company With Change Date

6 months ago on 31 Jul 2025

Appointment of Mrs Anna Mary Harcourt Fent as director on 2025-07-10

7 months ago on 15 Jul 2025